FDA Continues to Monitor Safety of Current COVID-19 Vaccines Available to the Public

FDA Continues to Monitor Safety of Current COVID-19 Vaccines Available to the Public

The FDA ensures it is doing its best to make sure each vaccine is completely safe to get.

The public trusts the FDA that all medical products, including the COVID-19 vaccines, are safe and effective. As a part of the standard process for inspecting all manufacturing facilities, the FDA recently completed an inspection of Emergent Biosolutions. This is a proposed manufacturing facility for the Johnson & Johnson vaccine.

Johnson & Johnson announced its facility is not authorized to distribute the vaccine in the U.S. The FDA investigations that are conducted are thorough and carefully thought out. These assessments include going through records, manufacturing procedures, staff training, facility operation and product quality. According to an article, during the inspection of Emergent Biosolutions that ended Tuesday, the FDA cited a number of requirements and standards that were not met.

The FDA is intended to identify these conditions then help identify a path to move forward to fix the issues and be safe. Emergent Biosolutions agreed to pause new productions while it undergoes additional testing and will be thoroughly evaluated before potentially distributing again.

These actions, however, are unrelated to an ongoing evaluation by the FDA and CDC of a specific blood clot reported in a very small number of people after receiving the Johnson & Johnson vaccine.

The FDA wants to ensure the COVID-19 vaccines that are distributed to everyone in the country have met the highest standards for quality, safety and effectiveness.

About the Author

Shereen Hashem is the Associate Content Editor for Occupational Health & Safety magazine.

Download Center

  • Safety Metrics Guide

    Is your company leveraging its safety data and analytics to maintain a safe workplace? With so much data available, where do you start? This downloadable guide will give you insight on helpful key performance indicators (KPIs) you should track for your safety program.

  • Job Hazard Analysis Guide

    This guide includes details on how to conduct a thorough Job Hazard Analysis, and it's based directly on an OSHA publication for conducting JHAs. Learn how to identify potential hazards associated with each task of a job and set controls to mitigate hazard risks.

  • A Guide to Practicing “New Safety”

    Learn from safety professionals from around the world as they share their perspectives on various “new views” of safety, including Safety Differently, Safety-II, No Safety, Human and Organizational Performance (HOP), Resilience Engineering, and more in this helpful guide.

  • Lone Worker Safety Guide

    As organizations digitalize and remote operations become more commonplace, the number of lone workers is on the rise. These employees are at increased risk for unaddressed workplace accidents or emergencies. This guide was created to help employers better understand common lone worker risks and solutions for lone worker risk mitigation and incident prevention.

  • EHS Software Buyer's Guide

    Learn the keys to staying organized, staying sharp, and staying one step ahead on all things safety. This buyer’s guide is designed for you to use in your search for the safety management solution that best suits your company’s needs.

  • Vector Solutions

Featured Whitepaper

OH&S Digital Edition

  • OHS Magazine Digital Edition - June 2022

    June 2022


      Corporate Safety Culture Is Workplace Culture
      Keeping Workers Safe from Heat-Related Illnesses & Injuries
      Should Employers Consider Oral Fluid Drug Testing?
      Addressing Physical Differences
    View This Issue